Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension

Purpose In rats, chronic aldosterone administration with high diet intake increases aortic stiffness independent of mechanical stress. In hypertensive humans, enhanced plasma aldosterone and arterial stiffness are positively associated. Whether the aldosterone synthase gene polymorphism (ASGP) CYP11B2 influences the age-related changes in blood pressure (BP) and arterial stiffness in hypertensive subjects has never been investigated. Methods In 425 untreated hypertensive men and women, ASGP was evaluated together with aortic pulse wave velocity (PWV). In 191 of these subjects, cardiac haemodynamics were measured using echo-Doppler techniques. Results In the overall population, independently of sex, the TC and CC genotypes of ASPG had significantly higher heart rate (HR) (P < 0.05) and lower stroke index (P < 0.01) than the TT genotype, but did not affect BP. In men, the adjusted slopes of the curves relating age to PWV and HR were significantly steeper (P = 0.04; P = 0.002) for the TC and CC than for the TT genotype. Such gene-related differences were not observed for the age–systolic BP relationship. Conclusion In hypertensive subjects, the TC and CC genotypes of ASGP involve, by comparison with the TT genotype, significantly higher HR and reduced stroke index. In men with the C allele, the reduced stroke index (cardiac effect) compensates for the steep increase of PWV with age (arterial effect), thus modulating the cardiovascular phenotype and explaining the lack of increased incidence of systolic hypertension. The results are consistent with a local role of endogenous aldosterone on both heart and vessels.

[1]  J. Staessen,et al.  Association of peripheral and central arterial wave reflections with the CYP11B2 –344C allele and sodium excretion , 2004, Journal of hypertension.

[2]  M. Safar,et al.  Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects , 2004, Journal of hypertension.

[3]  D. Hayoz,et al.  Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. , 2004, Journal of hypertension.

[4]  M. Safar,et al.  Angiotensin-Converting Enzyme D/I Gene Polymorphism and Age-Related Changes in Pulse Pressure in Subjects with Hypertension , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Connell,et al.  Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? , 2003, Hypertension.

[6]  M. Safar,et al.  Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone , 2002, Circulation.

[7]  Kathryn Bean,et al.  Determinants of Accelerated Progression of Arterial Stiffness in Normotensive Subjects and in Treated Hypertensive Subjects Over a 6-Year Period , 2002, Circulation.

[8]  Y. Nikitin,et al.  European Project on Genes in Hypertension , 2002 .

[9]  P Albaladejo,et al.  Heart Rate, Arterial Stiffness, and Wave Reflections in Paced Patients , 2001, Hypertension.

[10]  M E Safar,et al.  Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol , 2001, Hypertension.

[11]  F. Cambien,et al.  Angiotensin II type 1 receptor−153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects , 2001, Journal of hypertension.

[12]  M. Safar,et al.  Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. , 2001, Journal of the American College of Cardiology.

[13]  M. Safar Pulse pressure, arterial stiffness, and cardiovascular risk. , 2000, Current opinion in cardiology.

[14]  H. Huikuri,et al.  Baroreflex sensitivity and variants of the renin angiotensin system genes. , 2000, Journal of the American College of Cardiology.

[15]  S. Rosenfeld,et al.  Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. , 1999, Circulation.

[16]  C. Hengstenberg,et al.  Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. , 1999, Circulation.

[17]  P. White,et al.  Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  F. Luft,et al.  Molecular genetics of human hypertension. , 1998, Current opinion in cardiology.

[19]  J. Cohn,et al.  Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. , 1998, European heart journal.

[20]  F. Cambien,et al.  Genetic determination of plasma aldosterone levels in essential hypertension. , 1998, American journal of hypertension.

[21]  R. Carretta McDonaldʼs Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .

[22]  C. Delcayre,et al.  Myocardial Production of Aldosterone and Corticosterone in the Rat , 1998, The Journal of Biological Chemistry.

[23]  P. White,et al.  Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. , 1998, Circulation.

[24]  J. Blacher,et al.  Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. , 1997, American journal of hypertension.

[25]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[26]  M. Safar,et al.  Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Funder Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. , 1997, Annual review of medicine.

[28]  I. Miyamori,et al.  Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. , 1996, The Journal of clinical endocrinology and metabolism.

[29]  畠山 治彦 Vascular aldosterone : biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells , 1995 .

[30]  W. Wang,et al.  Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. , 1994, Hypertension.

[31]  R. Dilley,et al.  Mineralocorticoids, hypertension, and cardiac fibrosis. , 1994, The Journal of clinical investigation.

[32]  K. Weber,et al.  Myocardial fibrosis: role of angiotensin II and aldosterone. , 1993, Basic research in cardiology.

[33]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[34]  E. Baulieu,et al.  Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. , 1992, Circulation research.

[35]  T. Brewer ARTERIAL PRESSURE AND HYPERTENSION , 1981 .

[36]  M. Safar,et al.  Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. , 1977, Archives of internal medicine.